Case report: anti-NMDA receptor encephalitis in a patient with small cell carcinoma of presumed bladder origin: a potential paraneoplastic association

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune disorder caused by IgG autoantibodies targeting the NMDAR GluN1 (NR1) subunit leading to reduced receptor-dependent synaptic currents. Although most commonly associated with ovarian teratomas in young women, paraneoplastic cases in older adults are less frequent and may pose diagnostic challenges. We report a case of a 74-year-old male presenting with progressive confusion, visual hallucinations, agitation, and abnormal movements, who was ultimately diagnosed with anti-NMDAR encephalitis based on characteristic clinical features and repeated cerebrospinal fluid (CSF) NMDAR antibody positivity. His course was marked by severe encephalitis with persistent neurologic impairment despite first-line therapy and escalation to second-line encephalitis-directed immunomodulatory treatment. Concurrent oncologic evaluation revealed metastatic high-grade neuroendocrine carcinoma with a presumed bladder primary, most consistent with small cell carcinoma of the bladder (SCCB), a malignancy not previously reported in association with anti-NMDAR encephalitis to our knowledge. Although the coexistence of these conditions raised concern for a possible paraneoplastic process, the available findings were insufficient to establish a definite paraneoplastic neurologic syndrome under the PNS-Care framework. Treatment included encephalitis-directed therapy with intravenous immunoglobulin (IVIG), high-dose corticosteroids, and enrollment in the ExTINGUISH trial (inebilizumab vs. placebo) as well as systemic chemotherapy, with gradual neurologic improvement and discharge to inpatient rehabilitation. This case highlights the importance of early malignancy screening and multidisciplinary management in older patients with autoimmune encephalitis and raises the possibility of an association between anti-NMDAR encephalitis and metastatic small cell carcinoma of presumed bladder origin.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-11-19
DOI
https://doi.org/10.3389/fonc.2026.1952485
Primary Topic
Autoimmune Neurological Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Case report: anti-NMDA receptor encephalitis in a patient with small cell carcinoma of presumed bladder origin: a potential paraneoplastic association

Adam McLain Kase, Oluwatayo Adeoye, Jordan Reynolds, Alina Maleski et al.
Frontiers in Oncology
Autoimmune Neurological Disorders and Treatments
article

Case report: anti-NMDA receptor encephalitis in a patient with small cell carcinoma of presumed bladder origin: a potential paraneoplastic association

Adam McLain Kase, Oluwatayo Adeoye, Jordan Reynolds, Alina Maleski, Lauren McLeod
article en

Abstract

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune disorder caused by IgG autoantibodies targeting the NMDAR GluN1 (NR1) subunit leading to reduced receptor-dependent synaptic currents. Although most commonly associated with ovarian teratomas in young women, paraneoplastic cases in older adults are less frequent and may pose diagnostic challenges. We report a case of a 74-year-old male presenting with progressive confusion, visual hallucinations, agitation, and abnormal movements, who was ultimately diagnosed with anti-NMDAR encephalitis based on characteristic clinical features and repeated cerebrospinal fluid (CSF) NMDAR antibody positivity. His course was marked by severe encephalitis with persistent neurologic impairment despite first-line therapy and escalation to second-line encephalitis-directed immunomodulatory treatment. Concurrent oncologic evaluation revealed metastatic high-grade neuroendocrine carcinoma with a presumed bladder primary, most consistent with small cell carcinoma of the bladder (SCCB), a malignancy not previously reported in association with anti-NMDAR encephalitis to our knowledge. Although the coexistence of these conditions raised concern for a possible paraneoplastic process, the available findings were insufficient to establish a definite paraneoplastic neurologic syndrome under the PNS-Care framework. Treatment included encephalitis-directed therapy with intravenous immunoglobulin (IVIG), high-dose corticosteroids, and enrollment in the ExTINGUISH trial (inebilizumab vs. placebo) as well as systemic chemotherapy, with gradual neurologic improvement and discharge to inpatient rehabilitation. This case highlights the importance of early malignancy screening and multidisciplinary management in older patients with autoimmune encephalitis and raises the possibility of an association between anti-NMDAR encephalitis and metastatic small cell carcinoma of presumed bladder origin.

Frontiers in OncologyVol. 16
Mayo Clinic (US), Jacksonville College (US), Mayo Clinic in Florida (US)
Autoimmune Neurological Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon